1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
source: pixabay.com

1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases

Leszek Ignatowicz, a researcher from Georgia State University, recently received a 5 year, almost 2 million dollar grant from the NIH for his investigation into multiple sclerosis (MS). This project…

Continue Reading 1.95 Million Dollar Grant from the NIH will Support Research for Multiple Sclerosis and Related Diseases
A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment
source: pixabay.com

A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment

According to a story from globenewswire.com, the biotechnology company CytoDyn Inc. has recently announced the initiation of a phase 2 clinical trial. This clinical trial will be testing the company's…

Continue Reading A New Phase 2 Trial Begins for Experimental Nonalcoholic Steatohepatitis Treatment

Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

Regeneron Pharmaceuticals recently announced that it is testing a medicine for the treatment and/or prevention of Covid-19. According to an article by CNN, the testing of its anti-SARS-CoV-2 antibody combination…

Continue Reading Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients

Parkinson's News Today recently published an article featuring a study in Italy showing the benefits of deep brain stimulation in patients with late-stage Parkinson’s disease. The history of the subthalamic…

Continue Reading A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients
The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
source: pixabay.com

The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has just approved a treatment for rare adult-onset Still's disease for the first time ever. The…

Continue Reading The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
Bevacizumab is Surprisingly Effective for Treating HHT
https://pixabay.com/en/laboratory-analysis-blood-2356180/

Bevacizumab is Surprisingly Effective for Treating HHT

This year, thanks to COVID-19, the European Hematology Association (EHA) took their annual conference online - but that didn't prevent some intriguing new insights and ideas. In a press release,…

Continue Reading Bevacizumab is Surprisingly Effective for Treating HHT

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)